Molly Gallagher

512 total citations
10 papers, 148 citations indexed

About

Molly Gallagher is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Molly Gallagher has authored 10 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Molly Gallagher's work include COVID-19 epidemiological studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Infective Endocarditis Diagnosis and Management (2 papers). Molly Gallagher is often cited by papers focused on COVID-19 epidemiological studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Infective Endocarditis Diagnosis and Management (2 papers). Molly Gallagher collaborates with scholars based in United States and Canada. Molly Gallagher's co-authors include Katia Koelle, Allan J. Weinstein, Christopher B. Brooke, Ruian Ke, Midge Leitch, Jill Beech, Catherine W. Kohn, Elías Abrutyn, Olubunmi Oladunjoye and Anthony A. Donato and has published in prestigious journals such as The American Naturalist, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Molly Gallagher

10 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Gallagher United States 8 48 38 23 21 19 10 148
Narayan Acharya United States 8 62 1.3× 55 1.4× 11 0.5× 4 0.2× 54 2.8× 21 253
Scott Chapman Australia 6 68 1.4× 56 1.5× 3 0.1× 9 0.4× 27 1.4× 9 227
Zhao-Yu Guo China 9 67 1.4× 23 0.6× 6 0.3× 10 0.5× 108 5.7× 26 229
Jonathan I. D. Hamley United Kingdom 9 139 2.9× 27 0.7× 3 0.1× 21 1.0× 58 3.1× 19 243
Waleed Aljabr Saudi Arabia 9 85 1.8× 90 2.4× 3 0.1× 11 0.5× 20 1.1× 20 195
Joris Vandeputte Belgium 8 141 2.9× 79 2.1× 2 0.1× 7 0.3× 9 0.5× 13 274
Susana Lloveras Argentina 8 57 1.2× 34 0.9× 12 0.5× 5 0.2× 67 3.5× 29 142
А. В. Топорков Russia 7 72 1.5× 45 1.2× 2 0.1× 25 1.2× 104 5.5× 87 201
A. Jeanine Abrams United States 13 63 1.3× 102 2.7× 6 0.3× 2 0.1× 68 3.6× 16 522
Tony Tat-Yin Chan China 5 173 3.6× 26 0.7× 3 0.1× 25 1.2× 27 1.4× 6 240

Countries citing papers authored by Molly Gallagher

Since Specialization
Citations

This map shows the geographic impact of Molly Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Gallagher more than expected).

Fields of papers citing papers by Molly Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Gallagher. The network helps show where Molly Gallagher may publish in the future.

Co-authorship network of co-authors of Molly Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Gallagher. A scholar is included among the top collaborators of Molly Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Gallagher. Molly Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Scobie, Heather M., Mark J. Panaggio, Alison M. Binder, et al.. (2023). Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators ― United States, October 1, 2020–March 22, 2023. MMWR Morbidity and Mortality Weekly Report. 72(19). 529–535. 12 indexed citations
2.
Kraay, Alicia N.M., Molly Gallagher, Yang Ge, et al.. (2022). The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2. Journal of The Royal Society Interface. 19(194). 20220477–20220477. 5 indexed citations
3.
Oladunjoye, Olubunmi, et al.. (2021). Mortality due to COVID-19 infection: A comparison of first and second waves. Journal of Community Hospital Internal Medicine Perspectives. 11(6). 747–752. 15 indexed citations
4.
Liu, Jiawei, et al.. (2019). Stochasticity and Infectious Disease Dynamics: Density and Weather Effects on a Fungal Insect Pathogen. The American Naturalist. 195(3). 504–523. 12 indexed citations
5.
Gallagher, Molly & Greg Dwyer. (2019). Combined Effects of Natural Enemies and Competition for Resources on a Forest Defoliator: A Theoretical and Empirical Analysis. The American Naturalist. 194(6). 807–822. 1 indexed citations
6.
Gallagher, Molly, Christopher B. Brooke, Ruian Ke, & Katia Koelle. (2018). Causes and Consequences of Spatial Within-Host Viral Spread. Viruses. 10(11). 627–627. 44 indexed citations
7.
Kim, Jae‐Young, et al.. (2015). Mutations in Caenorhabditis briggsae identify new genes important for limiting the response to EGF signaling during vulval development. Evolution & Development. 17(1). 34–48. 10 indexed citations
8.
Abrutyn, Elías, et al.. (1978). Cephalothin-gentamicin synergism in experimental enterococcal endocarditis. Journal of Antimicrobial Chemotherapy. 4(2). 153–158. 9 indexed citations
9.
Beech, Jill, Catherine W. Kohn, Midge Leitch, Allan J. Weinstein, & Molly Gallagher. (1977). Therapeutic Use of Gentamicin in Horses: Concentrations in Serum, Urine, and Synovial Fluid and Evaluation of Renal Function. American Journal of Veterinary Research. 38(7). 1085–1087. 30 indexed citations
10.
Weinstein, Allan J., et al.. (1977). Penicillinase-Resistant Penicillins Plus Gentamicin in Experimental Enterococcal Endocarditis. Antimicrobial Agents and Chemotherapy. 12(4). 484–489. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narayan Acharya Breakdown of academic impact, for papers by Scott Chapman Breakdown of academic impact, for papers by Zhao-Yu Guo Breakdown of academic impact, for papers by Jonathan I. D. Hamley Breakdown of academic impact, for papers by Waleed Aljabr Breakdown of academic impact, for papers by Joris Vandeputte Breakdown of academic impact, for papers by Susana Lloveras Breakdown of academic impact, for papers by А. В. Топорков Breakdown of academic impact, for papers by A. Jeanine Abrams Breakdown of academic impact, for papers by Tony Tat-Yin Chan
Rankless by CCL
2026